Semaglutide authorised as Ozempic is not currently recognised by regulators as causing specific vulvovaginal adverse reactions such as vaginal dryness, vulvovaginal candidiasis, altered discharge, dyspareunia, vaginal atrophy, or vaginal mucosal injury
However, its important to note that these peptides should only be used under the guidance of a qualified healthcare professional, as dosing and administration protocols may vary depending on individual needs and goals.
Long-term considerations: Understanding potential long-term effects, both positive and negative, informs research decisions
Step 5: Moving to 12.5 mg and preparing for maintenance At the 12.5 mg dose, youre approaching the higher end of the tirzepatide dosage chart
However, female subjects report higher rates of nausea at doses above 1mg compared to male subjects, likely due to sex differences in melanocortin-4 receptor density in the area postrema